附录素A1表达在小细胞肺癌中的作用
Ágnes Paál1,2,3,4, David Dora5, Ákos Takács1,2
1Department of Pharmacology and Pharmacotherapy, Semmelweis University, 1085 Budapest, Hungary.
Cancers
|May 14, 2025
概括
附录素A1 (ANXA1) 与小细胞肺癌 (SCLC) 免疫细胞增加和治疗耐药性有关. 沉默ANXA1降低了化疗敏感性,这表明ANXA1是SCLC的潜在治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 小细胞肺癌 (SCLC) 预后不好,治疗选择有限.
- 附录素A1 (ANXA1) 可能在SCLC的免疫抑制瘤微环境和癌症攻击性中发挥作用.
- 了解治疗耐药性的分子机制对于开发新型SCLC治疗至关重要.
研究的目的:
- 综合描述ANXA1表达在SCLC中的作用.
- 研究ANXA1对瘤细胞生物学和瘤微环境 (TME) 的影响.
- 探索ANXA1作为SCLC治疗点的潜力.
主要方法:
- 对公开可用的转录组数据和RNA-seq算法 (EPIC,ESTIMATE) 的分析.
- 在患者样本上进行免疫组织化学检测,以评估ANXA1蛋白质表达.
- 试验室研究涉及SCLC细胞系中的ANXA1沉默,以评估生长速度,化学敏感性和分子标记物变化.
主要成果:
- 高ANXA1表达与增加的免疫透物,流体性和瘤相关巨细胞 (TAMs) 相关联.
- ANXA1蛋白在SCLC细胞和TAMs上表达.
- 在测试的SCLC细胞系中,ANXA1沉默降低了对思丁和埃托胺的化学敏感性,尽管对增殖率的影响各不相同.
结论:
- 这项研究为SCLC中ANXA1提供了第一个全面的表征.
- ANXA1影响SCLC细胞生物学,瘤微环境和化学抵抗.
- 结果强调ANXA1作为改善SCLC治疗策略的潜在治疗点.
更多相关视频
08:49Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
Published on: May 27, 2016
11.0K
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
360
相关概念视频
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Selectins
3.2K
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
3.2K
